Read More Pharma Industry News Sanofi signs $1.45bn deal to acquire Kymab, expanding its immune-therapy pipeline In a significant move to bolster its immuno-oncology and immune-mediated disease portfolio, Sanofi has acquired Kymab, a UK-based… bypharmanewsdailyJanuary 12, 2021
